首页 > 最新文献

Annales De Dermatologie Et De Venereologie最新文献

英文 中文
Erythematous papule after patch testing. Is all that glitters really gold? 斑贴试验后的红斑丘疹。闪闪发光的真的都是金子吗？
IF 0.9 4区 医学 Q2 DERMATOLOGY
Annales De Dermatologie Et De Venereologie
Pub Date : 2024-02-01 DOI: 10.1016/j.annder.2023.103239
J. Gimeno Castillo, A. Onaindia Pérez, A. Saenz Aguirre
{"title":"Erythematous papule after patch testing. Is all that glitters really gold?","authors":"J. Gimeno Castillo, A. Onaindia Pérez, A. Saenz Aguirre","doi":"10.1016/j.annder.2023.103239","DOIUrl":"10.1016/j.annder.2023.103239","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 1","pages":"Article 103239"},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Encorafenib-induced eccrine squamous syringometaplasia 安柯拉非尼诱发的无阴道鳞状鞘膜增生症。
IF 0.9 4区 医学 Q2 DERMATOLOGY
Annales De Dermatologie Et De Venereologie
Pub Date : 2024-02-01 DOI: 10.1016/j.annder.2023.103241
A. Potereau, M. Carmi, F. Luquet-Plantier, V. Gras, A. Id Baih, A. Dadban, E. Carmi
{"title":"Encorafenib-induced eccrine squamous syringometaplasia","authors":"A. Potereau, M. Carmi, F. Luquet-Plantier, V. Gras, A. Id Baih, A. Dadban, E. Carmi","doi":"10.1016/j.annder.2023.103241","DOIUrl":"10.1016/j.annder.2023.103241","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"151 1","pages":"Article 103241"},"PeriodicalIF":0.9,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Teaching dermatology in the 21st century – The digital train has already left, but are we on it? 21世纪的皮肤病学教学——数字列车已经离开，但我们还在上面吗?
IF 0.9 4区 医学 Q2 DERMATOLOGY
Annales De Dermatologie Et De Venereologie
Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.03.011
A. Salava, N. Kluger
{"title":"Teaching dermatology in the 21st century – The digital train has already left, but are we on it?","authors":"A. Salava, N. Kluger","doi":"10.1016/j.annder.2023.03.011","DOIUrl":"10.1016/j.annder.2023.03.011","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"150 4","pages":"Page 286"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9695480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases 皮下泛膜炎样t细胞淋巴瘤表现为面部浸润，甲氨蝶呤长期有效:2例
IF 0.9 4区 医学 Q2 DERMATOLOGY
Annales De Dermatologie Et De Venereologie
Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.04.003
D. Marcé , D. Canu , C. Laurent , C. Pottier , M.-L. Jullie , T. Kervarrec , M. Beylot-Barry , M. Samimi
{"title":"Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases","authors":"D. Marcé , D. Canu , C. Laurent , C. Pottier , M.-L. Jullie , T. Kervarrec , M. Beylot-Barry , M. Samimi","doi":"10.1016/j.annder.2023.04.003","DOIUrl":"10.1016/j.annder.2023.04.003","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"150 4","pages":"Pages 294-296"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9775964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Omalizumab-induced paradoxical urticaria responsive to dupilumab omalizumab诱导的对dupilumab应答的矛盾荨麻疹
IF 0.9 4区 医学 Q2 DERMATOLOGY
Annales De Dermatologie Et De Venereologie
Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.007
A.-C. Fougerousse, A. Badaoui
{"title":"Omalizumab-induced paradoxical urticaria responsive to dupilumab","authors":"A.-C. Fougerousse, A. Badaoui","doi":"10.1016/j.annder.2023.06.007","DOIUrl":"10.1016/j.annder.2023.06.007","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"150 4","pages":"Pages 302-303"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10190217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer 阿扑胺治疗前列腺癌症后罕见且严重的地衣样皮肤出疹。
IF 0.9 4区 医学 Q2 DERMATOLOGY
Annales De Dermatologie Et De Venereologie
Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.09.001
P.-F. Guglielmini, C. Massone, C. Grasso, A. Francese, M. Vincenti, S. Chiodi, M. Rossi, A. Maconi
{"title":"A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer","authors":"P.-F. Guglielmini, C. Massone, C. Grasso, A. Francese, M. Vincenti, S. Chiodi, M. Rossi, A. Maconi","doi":"10.1016/j.annder.2023.09.001","DOIUrl":"10.1016/j.annder.2023.09.001","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"150 4","pages":"Pages 310-311"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71410298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec 蕈样肉芽肿和Sézary综合征的临床特征、初步治疗和预后：魁北克大学医院中心的一项回顾性单中心研究。
IF 0.9 4区 医学 Q2 DERMATOLOGY
Annales De Dermatologie Et De Venereologie
Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.006
M. Lachance, M.-M. Thibeault
{"title":"Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec","authors":"M. Lachance, M.-M. Thibeault","doi":"10.1016/j.annder.2023.06.006","DOIUrl":"10.1016/j.annder.2023.06.006","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"150 4","pages":"Pages 276-280"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41098196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin 面部血管纤维瘤伴结节性硬化症患者的调查：局部雷帕霉素的短期、中期和长期疗效和安全性。
IF 0.9 4区 医学 Q2 DERMATOLOGY
Annales De Dermatologie Et De Venereologie
Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.009
N. Sigg , J. Fouquet , D. Morin , D. Farges , S. Vrignaud , L. Martin

Aims

Topical rapamycin is used to reduce facial angiofibromas in patients with tuberous sclerosis (TSC). In the absence of a commercially available preparation, numerous formulations have been tested clinically, although only in the short term.

Methods

The pharmacy at Angers University Hospital (France) produced a cream formulation that was administered to people presenting this genetic disease. We conducted a questionnaire-based survey among 79 patients with TSC about their perceptions regarding the short-, medium- and long-term efficacy and safety of a topical rapamycin preparation in relation to facial angiofibromas.

Results

This formulation was very well tolerated and its efficacy was sustained over the long term with a mean treatment duration of 33 months (extremes 1–60). Efficacy was rated ≥ 8/10 by 67.1% of patients while safety was rated ≥ 8/10 by 84.8% of patients.

Conclusion

This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.

目的：局部雷帕霉素用于减少结节性硬化（TSC）患者的面部血管纤维瘤。在缺乏商业可用制剂的情况下，许多制剂已经进行了临床试验，尽管只是在短期内。方法：法国昂热大学医院的药房生产了一种乳膏配方，用于患有这种遗传性疾病的人。我们对79名TSC患者进行了一项基于问卷的调查，了解他们对雷帕霉素外用制剂治疗面部血管纤维瘤的短期、中期和长期疗效和安全性的看法。结果：该制剂具有良好的耐受性，其疗效长期持续，平均治疗时间为33 月（极端1-60）。对疗效进行了评级 ≥ 在安全性评定的情况下，67.1%的患者使用8/10 ≥ 8/10，占84.8%。结论：在79例TSC患者中，本调查支持局部雷帕霉素治疗面部血管纤维瘤的短期、中期和长期安全性和有效性。
{"title":"A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin","authors":"N. Sigg ,&nbsp;J. Fouquet ,&nbsp;D. Morin ,&nbsp;D. Farges ,&nbsp;S. Vrignaud ,&nbsp;L. Martin","doi":"10.1016/j.annder.2023.06.009","DOIUrl":"10.1016/j.annder.2023.06.009","url":null,"abstract":"<div><h3>Aims</h3><p><span>Topical rapamycin<span> is used to reduce facial angiofibromas<span> in patients with </span></span></span>tuberous sclerosis (TSC). In the absence of a commercially available preparation, numerous formulations have been tested clinically, although only in the short term.</p></div><div><h3>Methods</h3><p>The pharmacy at Angers University Hospital (France) produced a cream formulation that was administered to people presenting this genetic disease. We conducted a questionnaire-based survey among 79 patients with TSC about their perceptions regarding the short-, medium- and long-term efficacy and safety of a topical rapamycin preparation in relation to facial angiofibromas.</p></div><div><h3>Results</h3><p>This formulation was very well tolerated and its efficacy was sustained over the long term with a mean treatment duration of 33 months (extremes 1–60). Efficacy was rated ≥ 8/10 by 67.1% of patients while safety was rated ≥ 8/10 by 84.8% of patients.</p></div><div><h3>Conclusion</h3><p>This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.</p></div>","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"150 4","pages":"Pages 270-273"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41188901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous pseudolymphoma following sub-cutaneous immunotherapy for dust mites 皮肤假性淋巴瘤后皮下免疫治疗尘螨。
IF 0.9 4区 医学 Q2 DERMATOLOGY
Annales De Dermatologie Et De Venereologie
Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.09.002
A. Badaoui, I. Moulonguet
{"title":"Cutaneous pseudolymphoma following sub-cutaneous immunotherapy for dust mites","authors":"A. Badaoui,&nbsp;I. Moulonguet","doi":"10.1016/j.annder.2023.09.002","DOIUrl":"10.1016/j.annder.2023.09.002","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"150 4","pages":"Pages 312-313"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89716613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The carbon footprint of dermatologists: Time for a change? 皮肤科医生的碳足迹:是时候改变了?
IF 0.9 4区 医学 Q2 DERMATOLOGY
Annales De Dermatologie Et De Venereologie
Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.10.001
Nicolas Kluger
{"title":"The carbon footprint of dermatologists: Time for a change?","authors":"Nicolas Kluger","doi":"10.1016/j.annder.2023.10.001","DOIUrl":"10.1016/j.annder.2023.10.001","url":null,"abstract":"","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"150 4","pages":"Pages 251-252"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138433039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Annales De Dermatologie Et De Venereologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1